| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein kinase activity | DDR1 ABL2 CDK15 PSKH1 OBSCN SRMS CDK11A NUAK2 STK33 MAP3K9 MAP3K11 KDR ROS1 FAM20A MUSK CDK3 | 4.23e-05 | 600 | 166 | 16 | GO:0004672 |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 1.52e-04 | 13 | 166 | 3 | GO:0008046 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | DDR1 ABL2 CDK15 PSKH1 OBSCN SRMS CDK11A NUAK2 STK33 MAP3K9 MAP3K11 KDR ROS1 FAM20A MUSK CDK3 | 2.89e-04 | 709 | 166 | 16 | GO:0016773 |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 3.52e-04 | 17 | 166 | 3 | GO:0022848 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.20e-04 | 18 | 166 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | ROBO4 FN1 CALR KTN1 L1CAM OBSCN ACTN1 SLAMF1 PTPRT SVEP1 NISCH KDR ROBO3 EIF2A | 4.94e-04 | 599 | 166 | 14 | GO:0050839 |
| GeneOntologyMolecularFunction | kinase activity | DDR1 ABL2 CDK15 PSKH1 OBSCN SRMS CDK11A NUAK2 STK33 MAP3K9 MAP3K11 KDR ROS1 FAM20A MUSK CDK3 | 6.52e-04 | 764 | 166 | 16 | GO:0016301 |
| GeneOntologyMolecularFunction | integrin binding | 6.64e-04 | 175 | 166 | 7 | GO:0005178 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 8.84e-04 | 23 | 166 | 3 | GO:0015464 | |
| GeneOntologyMolecularFunction | ferroxidase activity | 1.01e-03 | 6 | 166 | 2 | GO:0004322 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on metal ions, oxygen as acceptor | 1.01e-03 | 6 | 166 | 2 | GO:0016724 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 1.18e-03 | 310 | 166 | 9 | GO:0030246 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CHL1 ROBO4 DSG1 L1CAM PCDH11Y IGSF11 PTPRT HMCN2 HMCN1 ROBO2 ROBO3 | 3.98e-07 | 187 | 168 | 11 | GO:0007156 |
| GeneOntologyBiologicalProcess | axon guidance | CHL1 ROBO4 HSPG2 L1CAM ISL2 DCC EFNB2 HMCN2 ROBO2 ROBO3 SEMA3E | 2.29e-05 | 285 | 168 | 11 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | CHL1 ROBO4 HSPG2 L1CAM ISL2 DCC EFNB2 HMCN2 ROBO2 ROBO3 SEMA3E | 2.37e-05 | 286 | 168 | 11 | GO:0097485 |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine autophosphorylation | 2.77e-05 | 22 | 168 | 4 | GO:0038083 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CHL1 ROBO4 DSG1 L1CAM PCDH11Y IGSF11 PTPRT HMCN2 HMCN1 ROBO2 ROBO3 | 5.38e-05 | 313 | 168 | 11 | GO:0098742 |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 1.09e-04 | 228 | 168 | 9 | GO:0046777 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | CHL1 ROBO4 HSPG2 DDR1 ABI3 ABL2 FN1 L1CAM ISL2 DCC SPG21 EFNB2 HMCN2 ROBO2 KDR ROBO3 PLEKHO1 SEMA3E | 1.29e-04 | 819 | 168 | 18 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell junction organization | ABI3 ABL2 LHFPL4 FN1 DSG1 L1CAM NBEA SYNPO IGSF11 ACTN1 PTPRT SVEP1 NF1 EFNB2 HMCN2 NCAN ROBO2 KDR MUSK SEMA3E | 1.35e-04 | 974 | 168 | 20 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | CASS4 DDR1 FN1 CALR L1CAM ACTN1 SVEP1 ADAMTS12 NF1 KDR EGFLAM SEMA3E | 1.41e-04 | 410 | 168 | 12 | GO:0031589 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | CHL1 ROBO4 HSPG2 DDR1 ABI3 ABL2 FN1 L1CAM ISL2 DCC SPG21 EFNB2 HMCN2 ROBO2 KDR ROBO3 PLEKHO1 SEMA3E | 1.44e-04 | 826 | 168 | 18 | GO:0048858 |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 1.50e-04 | 238 | 168 | 9 | GO:0050954 | |
| GeneOntologyBiologicalProcess | synapse organization | ABI3 ABL2 LHFPL4 L1CAM NBEA SYNPO IGSF11 ACTN1 PTPRT NF1 EFNB2 HMCN2 NCAN ROBO2 MUSK SEMA3E | 1.57e-04 | 685 | 168 | 16 | GO:0050808 |
| GeneOntologyBiologicalProcess | sensory perception of sound | 2.25e-04 | 198 | 168 | 8 | GO:0007605 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate adhesion | 2.44e-04 | 254 | 168 | 9 | GO:0010810 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL5A2 HSPG2 DDR1 ABL2 FN1 PRDX4 ADAMTS12 NF1 HMCN1 ADAMTS16 EGFLAM | 2.75e-04 | 377 | 168 | 11 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL5A2 HSPG2 DDR1 ABL2 FN1 PRDX4 ADAMTS12 NF1 HMCN1 ADAMTS16 EGFLAM | 2.81e-04 | 378 | 168 | 11 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL5A2 HSPG2 DDR1 ABL2 FN1 PRDX4 ADAMTS12 NF1 HMCN1 ADAMTS16 EGFLAM | 2.88e-04 | 379 | 168 | 11 | GO:0045229 |
| GeneOntologyCellularComponent | inner dynein arm | 7.95e-07 | 10 | 167 | 4 | GO:0036156 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 4.36e-05 | 25 | 167 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | basement membrane | 5.68e-05 | 122 | 167 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | extracellular matrix | COL5A2 HSPG2 FN1 CD248 CALR L1CAM LAMA4 SVEP1 ADAMTS12 TGM4 HMCN2 HMCN1 NCAN ADAMTS16 EGFLAM USH2A | 7.62e-05 | 656 | 167 | 16 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL5A2 HSPG2 FN1 CD248 CALR L1CAM LAMA4 SVEP1 ADAMTS12 TGM4 HMCN2 HMCN1 NCAN ADAMTS16 EGFLAM USH2A | 7.90e-05 | 658 | 167 | 16 | GO:0030312 |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 3.74e-04 | 18 | 167 | 3 | GO:0005892 | |
| GeneOntologyCellularComponent | synaptic membrane | LHFPL4 L1CAM NBEA DCC GRM8 CHRNA2 CHRNA4 PTPRT CHRNB3 EFNB2 SCN2A ROBO2 MUSK | 8.43e-04 | 583 | 167 | 13 | GO:0097060 |
| GeneOntologyCellularComponent | dynein complex | 9.10e-04 | 54 | 167 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | cortical granule | 9.32e-04 | 6 | 167 | 2 | GO:0060473 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL5A2 HSPG2 FN1 CALR L1CAM LAMA4 TGM4 HMCN2 HMCN1 NCAN EGFLAM USH2A | 1.17e-03 | 530 | 167 | 12 | GO:0062023 |
| Domain | Ig_I-set | CHL1 ROBO4 HSPG2 L1CAM OBSCN IGSF11 DCC IGSF10 HMCN2 HMCN1 ROBO2 KDR MYOM2 ROBO3 MUSK | 1.55e-10 | 190 | 166 | 15 | IPR013098 |
| Domain | I-set | CHL1 ROBO4 HSPG2 L1CAM OBSCN IGSF11 DCC IGSF10 HMCN2 HMCN1 ROBO2 KDR MYOM2 ROBO3 MUSK | 1.55e-10 | 190 | 166 | 15 | PF07679 |
| Domain | fn3 | CHL1 ROBO4 FN1 L1CAM OBSCN DCC PTPRT TRIM9 ROBO2 ROS1 EGFLAM MYOM2 ROBO3 USH2A | 1.96e-10 | 162 | 166 | 14 | PF00041 |
| Domain | FN3 | CHL1 ROBO4 IL13RA2 FN1 L1CAM OBSCN DCC PTPRT TRIM9 ROBO2 ROS1 EGFLAM MYOM2 ROBO3 USH2A | 2.97e-10 | 199 | 166 | 15 | PS50853 |
| Domain | FN3_dom | CHL1 ROBO4 IL13RA2 FN1 L1CAM OBSCN DCC PTPRT TRIM9 ROBO2 ROS1 EGFLAM MYOM2 ROBO3 USH2A | 5.90e-10 | 209 | 166 | 15 | IPR003961 |
| Domain | FN3 | CHL1 ROBO4 FN1 L1CAM OBSCN DCC PTPRT TRIM9 ROBO2 ROS1 EGFLAM MYOM2 ROBO3 USH2A | 1.13e-09 | 185 | 166 | 14 | SM00060 |
| Domain | IGc2 | CHL1 ROBO4 HSPG2 L1CAM OBSCN IGSF11 DCC IGSF10 HMCN2 HMCN1 ROBO2 KDR MYOM2 ROBO3 MUSK | 2.98e-09 | 235 | 166 | 15 | SM00408 |
| Domain | Ig_sub2 | CHL1 ROBO4 HSPG2 L1CAM OBSCN IGSF11 DCC IGSF10 HMCN2 HMCN1 ROBO2 KDR MYOM2 ROBO3 MUSK | 2.98e-09 | 235 | 166 | 15 | IPR003598 |
| Domain | Ig-like_fold | CHL1 ROBO4 HSPG2 IL13RA2 FN1 L1CAM OBSCN IGSF11 DCC PTPRT IGSF10 TGM4 HMCN2 HMCN1 TRIM9 NCAN ROBO2 KDR ROS1 EGFLAM MYOM2 ROBO3 USH2A MUSK SEMA3E | 3.60e-09 | 706 | 166 | 25 | IPR013783 |
| Domain | - | CHL1 ROBO4 HSPG2 IL13RA2 FN1 L1CAM OBSCN IGSF11 DCC PTPRT IGSF10 TGM4 HMCN1 TRIM9 NCAN ROBO2 KDR ROS1 EGFLAM MYOM2 ROBO3 USH2A MUSK SEMA3E | 5.00e-09 | 663 | 166 | 24 | 2.60.40.10 |
| Domain | IG | CHL1 ROBO4 HSPG2 L1CAM OBSCN IGSF11 DCC PTPRT IGSF10 HMCN2 HMCN1 NCAN ROBO2 KDR MYOM2 ROBO3 MUSK SEMA3E | 4.07e-08 | 421 | 166 | 18 | SM00409 |
| Domain | Ig_sub | CHL1 ROBO4 HSPG2 L1CAM OBSCN IGSF11 DCC PTPRT IGSF10 HMCN2 HMCN1 NCAN ROBO2 KDR MYOM2 ROBO3 MUSK SEMA3E | 4.07e-08 | 421 | 166 | 18 | IPR003599 |
| Domain | IG_LIKE | CHL1 ROBO4 HSPG2 L1CAM OBSCN IGSF11 DCC SLAMF1 PTPRT IGSF10 HMCN2 HMCN1 NCAN ROBO2 KDR MYOM2 ROBO3 MUSK SEMA3E | 8.08e-08 | 491 | 166 | 19 | PS50835 |
| Domain | Ig-like_dom | CHL1 ROBO4 HSPG2 L1CAM OBSCN IGSF11 DCC SLAMF1 PTPRT IGSF10 HMCN2 HMCN1 NCAN ROBO2 KDR MYOM2 ROBO3 MUSK SEMA3E | 1.18e-07 | 503 | 166 | 19 | IPR007110 |
| Domain | Tyr_kinase_cat_dom | 1.16e-06 | 88 | 166 | 8 | IPR020635 | |
| Domain | TyrKc | 1.16e-06 | 88 | 166 | 8 | SM00219 | |
| Domain | - | 2.07e-06 | 95 | 166 | 8 | 2.60.120.200 | |
| Domain | EGF_1 | HSPG2 FN1 CD248 LAMA4 F10 SVEP1 HMCN2 HMCN1 ATRNL1 NCAN EGFLAM USH2A | 3.07e-06 | 255 | 166 | 12 | PS00022 |
| Domain | EGF_CA | 1.34e-05 | 122 | 166 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.51e-05 | 124 | 166 | 8 | IPR001881 | |
| Domain | PROTEIN_KINASE_ATP | DDR1 ABL2 CDK15 PSKH1 OBSCN SRMS CDK11A NUAK2 STK33 MAP3K9 MAP3K11 KDR ROS1 MUSK CDK3 | 1.54e-05 | 459 | 166 | 15 | PS00107 |
| Domain | EGF-like_CS | HSPG2 FN1 CD248 LAMA4 F10 SVEP1 HMCN2 HMCN1 ATRNL1 NCAN EGFLAM | 2.25e-05 | 261 | 166 | 11 | IPR013032 |
| Domain | PROTEIN_KINASE_TYR | 2.53e-05 | 97 | 166 | 7 | PS00109 | |
| Domain | Tyr_kinase_AS | 2.53e-05 | 97 | 166 | 7 | IPR008266 | |
| Domain | ConA-like_dom | 2.71e-05 | 219 | 166 | 10 | IPR013320 | |
| Domain | Prot_kinase_dom | DDR1 ABL2 CDK15 PSKH1 OBSCN SRMS CDK11A NUAK2 STK33 MAP3K9 MAP3K11 KDR ROS1 MUSK CDK3 | 3.21e-05 | 489 | 166 | 15 | IPR000719 |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 3.28e-05 | 138 | 166 | 8 | IPR001245 | |
| Domain | PROTEIN_KINASE_DOM | DDR1 ABL2 CDK15 PSKH1 OBSCN SRMS CDK11A NUAK2 STK33 MAP3K9 MAP3K11 KDR ROS1 MUSK CDK3 | 3.53e-05 | 493 | 166 | 15 | PS50011 |
| Domain | Protein_kinase_ATP_BS | ABL2 CDK15 PSKH1 OBSCN SRMS NUAK2 STK33 MAP3K9 MAP3K11 KDR ROS1 MUSK CDK3 | 3.54e-05 | 379 | 166 | 13 | IPR017441 |
| Domain | EGF-like_dom | 7.98e-05 | 249 | 166 | 10 | IPR000742 | |
| Domain | Kinase-like_dom | DDR1 ABL2 CDK15 PSKH1 OBSCN SRMS CDK11A NUAK2 STK33 MAP3K9 MAP3K11 KDR ROS1 MUSK CDK3 | 1.02e-04 | 542 | 166 | 15 | IPR011009 |
| Domain | EGF | 1.34e-04 | 126 | 166 | 7 | PF00008 | |
| Domain | EGF_LAM_2 | 1.38e-04 | 30 | 166 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 1.38e-04 | 30 | 166 | 4 | PS01248 | |
| Domain | SH3 | 1.38e-04 | 216 | 166 | 9 | SM00326 | |
| Domain | SH3 | 1.38e-04 | 216 | 166 | 9 | PS50002 | |
| Domain | Pkinase_Tyr | 1.56e-04 | 129 | 166 | 7 | PF07714 | |
| Domain | SH3_domain | 1.59e-04 | 220 | 166 | 9 | IPR001452 | |
| Domain | - | TBL1Y EML6 NBEA DNAI3 DMXL1 WDR6 NUP133 WDR90 EIF2A TBL1X SEMA3E | 1.99e-04 | 333 | 166 | 11 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | TBL1Y EML6 NBEA DNAI3 DMXL1 WDR6 NUP133 WDR90 EIF2A TBL1X SEMA3E | 2.09e-04 | 335 | 166 | 11 | IPR015943 |
| Domain | EGF_Ca-bd_CS | 2.28e-04 | 97 | 166 | 6 | IPR018097 | |
| Domain | FN_type2_col-bd | 2.34e-04 | 14 | 166 | 3 | IPR000562 | |
| Domain | FN2_2 | 2.34e-04 | 14 | 166 | 3 | PS51092 | |
| Domain | Dynein_HC_stalk | 2.34e-04 | 14 | 166 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.34e-04 | 14 | 166 | 3 | IPR013602 | |
| Domain | DHC_N2 | 2.34e-04 | 14 | 166 | 3 | PF08393 | |
| Domain | FN2_1 | 2.34e-04 | 14 | 166 | 3 | PS00023 | |
| Domain | - | 2.34e-04 | 14 | 166 | 3 | 2.60.40.420 | |
| Domain | MT | 2.34e-04 | 14 | 166 | 3 | PF12777 | |
| Domain | fn2 | 2.34e-04 | 14 | 166 | 3 | PF00040 | |
| Domain | FN2 | 2.34e-04 | 14 | 166 | 3 | SM00059 | |
| Domain | MULTICOPPER_OXIDASE2 | 2.34e-04 | 3 | 166 | 2 | PS00080 | |
| Domain | EGF_Lam | 2.54e-04 | 35 | 166 | 4 | SM00180 | |
| Domain | EGF_CA | 2.55e-04 | 99 | 166 | 6 | PS01187 | |
| Domain | EGF | 2.59e-04 | 235 | 166 | 9 | SM00181 | |
| Domain | EGF_3 | 2.59e-04 | 235 | 166 | 9 | PS50026 | |
| Domain | DHC_fam | 2.90e-04 | 15 | 166 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 2.90e-04 | 15 | 166 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.90e-04 | 15 | 166 | 3 | IPR004273 | |
| Domain | LAM_G_DOMAIN | 3.51e-04 | 38 | 166 | 4 | PS50025 | |
| Domain | Laminin_EGF | 3.51e-04 | 38 | 166 | 4 | IPR002049 | |
| Domain | Nicotinic_acetylcholine_rcpt | 3.55e-04 | 16 | 166 | 3 | IPR002394 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.69e-04 | 106 | 166 | 6 | IPR000152 | |
| Domain | Ig_V-set | 4.14e-04 | 199 | 166 | 8 | IPR013106 | |
| Domain | Laminin_G_2 | 4.29e-04 | 40 | 166 | 4 | PF02210 | |
| Domain | Neurofascin/L1/NrCAM_C | 4.66e-04 | 4 | 166 | 2 | IPR026966 | |
| Domain | Neural_cell_adh | 4.66e-04 | 4 | 166 | 2 | IPR009138 | |
| Domain | G2F | 4.66e-04 | 4 | 166 | 2 | PF07474 | |
| Domain | Cu-oxidase_2 | 4.66e-04 | 4 | 166 | 2 | IPR011706 | |
| Domain | NIDOGEN_G2 | 4.66e-04 | 4 | 166 | 2 | PS50993 | |
| Domain | GFP | 4.66e-04 | 4 | 166 | 2 | IPR009017 | |
| Domain | Bravo_FIGEY | 4.66e-04 | 4 | 166 | 2 | PF13882 | |
| Domain | MLK1/MLK2/MLK4 | 4.66e-04 | 4 | 166 | 2 | IPR016231 | |
| Domain | G2_nidogen/fibulin_G2F | 4.66e-04 | 4 | 166 | 2 | IPR006605 | |
| Domain | MAP3K10 | 4.66e-04 | 4 | 166 | 2 | IPR015785 | |
| Domain | Cu-oxidase_2 | 4.66e-04 | 4 | 166 | 2 | PF07731 | |
| Domain | IGv | 5.46e-04 | 75 | 166 | 5 | SM00406 | |
| Domain | LamG | 6.19e-04 | 44 | 166 | 4 | SM00282 | |
| Domain | EGF_2 | 6.21e-04 | 265 | 166 | 9 | PS01186 | |
| Domain | SH3_9 | 6.53e-04 | 78 | 166 | 5 | PF14604 | |
| Domain | C_TYPE_LECTIN_1 | 7.33e-04 | 80 | 166 | 5 | PS00615 | |
| Domain | Cu-oxidase_3 | 7.72e-04 | 5 | 166 | 2 | IPR011707 | |
| Domain | MULTICOPPER_OXIDASE1 | 7.72e-04 | 5 | 166 | 2 | PS00079 | |
| Domain | Cu_oxidase_CS | 7.72e-04 | 5 | 166 | 2 | IPR033138 | |
| Domain | Cu-oxidase_3 | 7.72e-04 | 5 | 166 | 2 | PF07732 | |
| Domain | - | 8.64e-04 | 48 | 166 | 4 | 2.120.10.80 | |
| Domain | WD_REPEATS_1 | 8.73e-04 | 278 | 166 | 9 | PS00678 | |
| Domain | WD_REPEATS_2 | 8.95e-04 | 279 | 166 | 9 | PS50082 | |
| Domain | WD_REPEATS_REGION | 8.95e-04 | 279 | 166 | 9 | PS50294 | |
| Domain | Lectin_C | 9.15e-04 | 84 | 166 | 5 | PF00059 | |
| Domain | CLECT | 9.15e-04 | 84 | 166 | 5 | SM00034 | |
| Domain | Cupredoxin | 9.38e-04 | 22 | 166 | 3 | IPR008972 | |
| Domain | C_TYPE_LECTIN_2 | 9.66e-04 | 85 | 166 | 5 | PS50041 | |
| Domain | SH3_2 | 1.02e-03 | 86 | 166 | 5 | PF07653 | |
| Domain | C-type_lectin-like | 1.02e-03 | 86 | 166 | 5 | IPR001304 | |
| Domain | SH3_2 | 1.02e-03 | 86 | 166 | 5 | IPR011511 | |
| Domain | - | 1.07e-03 | 23 | 166 | 3 | 1.20.120.370 | |
| Domain | Acetylcholine_rcpt_TM | 1.07e-03 | 23 | 166 | 3 | IPR027361 | |
| Domain | Cu_oxidase_Cu_BS | 1.15e-03 | 6 | 166 | 2 | IPR002355 | |
| Domain | Quinoprotein_ADH-like_supfam | 1.26e-03 | 53 | 166 | 4 | IPR011047 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 9.04e-06 | 59 | 117 | 6 | M27218 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.91e-05 | 76 | 117 | 6 | M27219 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL5A2 HSPG2 DDR1 FN1 LAMA4 ACTN1 CAPN10 NCAN ADAMTS16 KDR MUSK | 3.96e-05 | 300 | 117 | 11 | M610 |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 4.51e-05 | 9 | 117 | 3 | M27597 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 4.51e-05 | 9 | 117 | 3 | MM15313 | |
| Pathway | REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO | 6.41e-05 | 10 | 117 | 3 | M27348 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 8.76e-05 | 11 | 117 | 3 | M883 | |
| Pathway | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.16e-04 | 12 | 117 | 3 | M48008 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.16e-04 | 12 | 117 | 3 | MM15312 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 1.90e-04 | 14 | 117 | 3 | M757 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 2.36e-04 | 15 | 117 | 3 | MM14704 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ABL2 DSG1 KTN1 OBSCN ACTN1 PLEKHG1 RHPN2 WDR6 NISCH MAP3K11 FAM135A TOR1AIP1 | 2.85e-04 | 439 | 117 | 12 | MM15595 |
| Pathway | KEGG_OTHER_GLYCAN_DEGRADATION | 2.88e-04 | 16 | 117 | 3 | M17844 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ABL2 DSG1 KTN1 OBSCN ACTN1 PLEKHG1 RHPN2 WDR6 NISCH MAP3K11 FAM135A TOR1AIP1 | 3.57e-04 | 450 | 117 | 12 | M27078 |
| Pathway | REACTOME_RND3_GTPASE_CYCLE | 3.95e-04 | 42 | 117 | 4 | M41826 | |
| Pathway | REACTOME_RND3_GTPASE_CYCLE | 3.95e-04 | 42 | 117 | 4 | MM15677 | |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 4.33e-04 | 43 | 117 | 4 | M41827 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 4.33e-04 | 43 | 117 | 4 | M53 | |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 4.74e-04 | 44 | 117 | 4 | MM15678 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 4.90e-04 | 19 | 117 | 3 | MM15512 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 6.58e-04 | 288 | 117 | 9 | M16864 | |
| Pathway | KEGG_AXON_GUIDANCE | 7.13e-04 | 129 | 117 | 6 | M5539 | |
| Pubmed | 3.98e-08 | 8 | 172 | 4 | 31392959 | ||
| Pubmed | 3.98e-08 | 8 | 172 | 4 | 30893602 | ||
| Pubmed | 1.19e-07 | 3 | 172 | 3 | 17357069 | ||
| Pubmed | 1.27e-07 | 162 | 172 | 9 | 25826454 | ||
| Pubmed | 2.77e-07 | 12 | 172 | 4 | 16973135 | ||
| Pubmed | Robo2 is required for Slit-mediated intraretinal axon guidance. | 2.77e-07 | 12 | 172 | 4 | 19782674 | |
| Pubmed | 3.99e-07 | 13 | 172 | 4 | 25366972 | ||
| Pubmed | Genetic analyses of roundabout (ROBO) axon guidance receptors in autism. | 4.74e-07 | 4 | 172 | 3 | 18270976 | |
| Pubmed | 4.74e-07 | 4 | 172 | 3 | 28691197 | ||
| Pubmed | 4.74e-07 | 4 | 172 | 3 | 31036704 | ||
| Pubmed | 7.56e-07 | 15 | 172 | 4 | 26395479 | ||
| Pubmed | Disruption of the talin gene arrests mouse development at the gastrulation stage. | 1.18e-06 | 5 | 172 | 3 | 11084655 | |
| Pubmed | 2.35e-06 | 6 | 172 | 3 | 8808709 | ||
| Pubmed | Robo1 regulates the development of major axon tracts and interneuron migration in the forebrain. | 2.35e-06 | 6 | 172 | 3 | 16690755 | |
| Pubmed | VEGF signaling through neuropilin 1 guides commissural axon crossing at the optic chiasm. | 2.63e-06 | 20 | 172 | 4 | 21658587 | |
| Pubmed | Mapping of the murine tbl1 gene reveals a new rearrangement between mouse and human X Chromosomes. | 4.10e-06 | 7 | 172 | 3 | 9880679 | |
| Pubmed | 4.10e-06 | 7 | 172 | 3 | 20231857 | ||
| Pubmed | 4.10e-06 | 7 | 172 | 3 | 20434998 | ||
| Pubmed | Chromosomal localization of seven neuronal nicotinic acetylcholine receptor subunit genes in humans. | 4.10e-06 | 7 | 172 | 3 | 1505988 | |
| Pubmed | A tug of war between DCC and ROBO1 signaling during commissural axon guidance. | 4.10e-06 | 7 | 172 | 3 | 37149867 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 4.41e-06 | 248 | 172 | 9 | 24006456 | |
| Pubmed | TPP2 ZSWIM8 FN1 CALR PRDX4 ZNF318 ACTN1 NF1 AP1B1 ANAPC1 WDR6 NUP133 UTP20 TP53 | 5.13e-06 | 653 | 172 | 14 | 22586326 | |
| Pubmed | 6.54e-06 | 8 | 172 | 3 | 17559419 | ||
| Pubmed | VEGF mediates commissural axon chemoattraction through its receptor Flk1. | 6.54e-06 | 8 | 172 | 3 | 21658588 | |
| Pubmed | 6.54e-06 | 8 | 172 | 3 | 26037503 | ||
| Pubmed | Robo4 is a vascular-specific receptor that inhibits endothelial migration. | 6.54e-06 | 8 | 172 | 3 | 12941633 | |
| Pubmed | 9.28e-06 | 27 | 172 | 4 | 35894043 | ||
| Pubmed | 9.77e-06 | 9 | 172 | 3 | 10704386 | ||
| Pubmed | 9.77e-06 | 9 | 172 | 3 | 10330409 | ||
| Pubmed | 9.77e-06 | 9 | 172 | 3 | 8906617 | ||
| Pubmed | 9.77e-06 | 9 | 172 | 3 | 19228980 | ||
| Pubmed | 9.77e-06 | 9 | 172 | 3 | 22806432 | ||
| Pubmed | 9.77e-06 | 9 | 172 | 3 | 10683176 | ||
| Pubmed | Collaborative and specialized functions of Robo1 and Robo2 in spinal commissural axon guidance. | 9.77e-06 | 9 | 172 | 3 | 20631173 | |
| Pubmed | 1.39e-05 | 10 | 172 | 3 | 20736995 | ||
| Pubmed | The transcription factor gene Nfib is essential for both lung maturation and brain development. | 1.43e-05 | 30 | 172 | 4 | 15632069 | |
| Pubmed | 1.45e-05 | 363 | 172 | 10 | 25036637 | ||
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | 1.79e-05 | 372 | 172 | 10 | 22939624 | |
| Pubmed | 1.90e-05 | 11 | 172 | 3 | 24355925 | ||
| Pubmed | 1.90e-05 | 11 | 172 | 3 | 12225896 | ||
| Pubmed | SVEP1 is an endogenous ligand for the orphan receptor PEAR1. | 1.90e-05 | 11 | 172 | 3 | 36792666 | |
| Pubmed | VEGF/VEGFR2 signaling regulates hippocampal axon branching during development. | 1.90e-05 | 11 | 172 | 3 | 31868583 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | FN1 KTN1 RPS13 OBSCN DNAH2 NBEA IGSF10 TRIM9 FAM120C AGL DENND4B MAP3K9 UTP20 CHD6 | 1.95e-05 | 736 | 172 | 14 | 29676528 |
| Pubmed | Tie2 regulates endocardial sprouting and myocardial trabeculation. | 2.26e-05 | 68 | 172 | 5 | 31112136 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 22161643 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 32492656 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 29669734 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 8921253 | ||
| Pubmed | Hairless expression attenuates apoptosis in a mouse model and the COS cell line; involvement of p53. | 2.43e-05 | 2 | 172 | 2 | 20886113 | |
| Pubmed | Mouse models for the p53 R72P polymorphism mimic human phenotypes. | 2.43e-05 | 2 | 172 | 2 | 20587514 | |
| Pubmed | LACE1 interacts with p53 and mediates its mitochondrial translocation and apoptosis. | 2.43e-05 | 2 | 172 | 2 | 27323408 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 20685892 | ||
| Pubmed | Neural adhesion molecules L1 and CHL1 are survival factors for motoneurons. | 2.43e-05 | 2 | 172 | 2 | 15880726 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 20012564 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 10330347 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 15319471 | ||
| Pubmed | Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. | 2.43e-05 | 2 | 172 | 2 | 20445540 | |
| Pubmed | Wild-type p53 controls the level of fibronectin expression in breast cancer cells. | 2.43e-05 | 2 | 172 | 2 | 28765903 | |
| Pubmed | Targeting PSAT1 to mitigate metastasis in tumors with p53-72Pro variant. | 2.43e-05 | 2 | 172 | 2 | 36788227 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 26080815 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 15533325 | ||
| Pubmed | Chr 19(A/J) modifies tumor resistance in a sex- and parent-of-origin-specific manner. | 2.43e-05 | 2 | 172 | 2 | 19347398 | |
| Pubmed | Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancers. | 2.43e-05 | 2 | 172 | 2 | 27159396 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 16098465 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 22718973 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 32036221 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 30589500 | ||
| Pubmed | The M-type receptor PLA2R regulates senescence through the p53 pathway. | 2.43e-05 | 2 | 172 | 2 | 19197340 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 26961950 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 26743472 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 16397217 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 37616542 | ||
| Pubmed | Cytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutations. | 2.43e-05 | 2 | 172 | 2 | 23729642 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 29794369 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 7982204 | ||
| Pubmed | Deleted in colorectal carcinoma suppresses metastasis in p53-deficient mammary tumours. | 2.43e-05 | 2 | 172 | 2 | 22358843 | |
| Pubmed | Haemangioblast commitment is initiated in the primitive streak of the mouse embryo. | 2.43e-05 | 2 | 172 | 2 | 15577911 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 7513709 | ||
| Pubmed | Sympathetic neuron survival and proliferation are prolonged by loss of p53 and neurofibromin. | 2.43e-05 | 2 | 172 | 2 | 9608530 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 7767977 | ||
| Pubmed | Scram1 is a modifier of spinal cord resistance for astrocytoma on mouse Chr 5. | 2.43e-05 | 2 | 172 | 2 | 22160242 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 19048115 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 32635925 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 26412325 | ||
| Pubmed | The Placental Ferroxidase Zyklopen Is Not Essential for Iron Transport to the Fetus in Mice. | 2.43e-05 | 2 | 172 | 2 | 34114013 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 3665768 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 19477430 | ||
| Pubmed | Revisiting the NPcis mouse model: A new tool to model plexiform neurofibroma. | 2.43e-05 | 2 | 172 | 2 | 38900740 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 19351849 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 26740650 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 17216419 | ||
| Pubmed | Mammalian hemicentin 1 is assembled into tracks in the extracellular matrix of multiple tissues. | 2.43e-05 | 2 | 172 | 2 | 32035013 | |
| Pubmed | Semaphorin3E-induced inflammation contributes to insulin resistance in dietary obesity. | 2.43e-05 | 2 | 172 | 2 | 24093674 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 10591653 | ||
| Pubmed | Characterization of the L1-neurocan-binding site. Implications for L1-L1 homophilic binding. | 2.43e-05 | 2 | 172 | 2 | 10934197 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 12121305 | ||
| Pubmed | Prolactin cooperates with loss of p53 to promote claudin-low mammary carcinomas. | 2.43e-05 | 2 | 172 | 2 | 23873024 | |
| Pubmed | Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects. | 2.43e-05 | 2 | 172 | 2 | 10973261 | |
| Pubmed | Mosaic analysis with double markers reveals tumor cell of origin in glioma. | 2.43e-05 | 2 | 172 | 2 | 21737130 | |
| Pubmed | EphrinB2 regulates VEGFR2 during dendritogenesis and hippocampal circuitry development. | 2.43e-05 | 2 | 172 | 2 | 31868584 | |
| GeneFamily | Fibronectin type III domain containing | CHL1 ROBO4 FN1 L1CAM OBSCN DCC PTPRT TRIM9 PTPRQ ROBO2 ROS1 EGFLAM MYOM2 ROBO3 USH2A | 7.05e-14 | 160 | 113 | 15 | 555 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | CHL1 ROBO4 HSPG2 L1CAM OBSCN IGSF11 DCC IGSF10 HMCN2 HMCN1 ROBO2 KDR MYOM2 ROBO3 MUSK | 7.73e-14 | 161 | 113 | 15 | 593 |
| GeneFamily | Immunoglobulin like domain containing | CHL1 HSPG2 DCC SLAMF1 PTPRT HMCN2 KDR MYOM2 ROBO3 MUSK SEMA3E | 3.48e-08 | 193 | 113 | 11 | 594 |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.11e-04 | 40 | 113 | 4 | 321 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 1.25e-04 | 16 | 113 | 3 | 173 | |
| GeneFamily | WD repeat domain containing | 2.41e-04 | 262 | 113 | 8 | 362 | |
| GeneFamily | Cyclin dependent kinases | 5.57e-04 | 26 | 113 | 3 | 496 | |
| GeneFamily | Fibulins | 1.06e-03 | 8 | 113 | 2 | 556 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.13e-03 | 41 | 113 | 3 | 1298 | |
| GeneFamily | Kelch like|BTB domain containing | 2.29e-03 | 42 | 113 | 3 | 617 | |
| GeneFamily | Dyneins, axonemal | 4.95e-03 | 17 | 113 | 2 | 536 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 6.18e-03 | 19 | 113 | 2 | 50 | |
| Coexpression | NABA_CORE_MATRISOME | COL5A2 HSPG2 FN1 LAMA4 SVEP1 IGSF10 HMCN2 HMCN1 NCAN EGFLAM USH2A | 2.08e-06 | 275 | 171 | 11 | M5884 |
| Coexpression | NABA_CORE_MATRISOME | 1.20e-05 | 270 | 171 | 10 | MM17057 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | CASS4 COL5A2 FN1 LAMA4 DNAI3 SVEP1 ADAMTS12 TMEM132C IGSF10 HMCN1 ROBO2 MUSK | 6.72e-12 | 181 | 172 | 12 | 9ede19228ba5c0668a9c06c915510b95585216ef |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL5A2 FN1 CD248 LAMA4 BCAT1 CP F10 SVEP1 IGSF10 ADGRD1 SEMA3E | 3.84e-10 | 200 | 172 | 11 | 6f7f015b5fa1f52374f2c7d9ba339012395eda5f |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | COL5A2 FN1 CD248 LAMA4 BCAT1 CP F10 SVEP1 IGSF10 ADGRD1 SEMA3E | 3.84e-10 | 200 | 172 | 11 | 3a164e3971bcd62b148b813171c103adb81f972e |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | CHL1 CASS4 COL5A2 FN1 LAMA4 DCC DNAI3 SVEP1 ADAMTS12 TMEM132C IGSF10 | 3.84e-10 | 200 | 172 | 11 | bd8cf33502adea320e91ca2af14e1911d88ad374 |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CD248 LAMA4 SYNPO PLA2R1 EFNB2 ROBO2 KDR MYOM2 UBE2QL1 SEMA3E | 1.44e-09 | 172 | 172 | 10 | 073a503dc922e3e3ac3528e249b0f8b74402110b |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OBSCN DCC HMCN1 SCN2A PTPRQ ADAMTS16 ROS1 MYOM2 MYO15A USH2A | 2.76e-09 | 184 | 172 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OBSCN DCC HMCN1 SCN2A PTPRQ ADAMTS16 ROS1 MYOM2 MYO15A USH2A | 2.76e-09 | 184 | 172 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | OBSCN DCC HMCN1 SCN2A PTPRQ ADAMTS16 ROS1 MYOM2 MYO15A USH2A | 2.76e-09 | 184 | 172 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | PND07|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.16e-09 | 192 | 172 | 10 | 8171a60df481195c39a7f740effcae8e4deb6ca7 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | CASS4 COL5A2 FN1 LAMA4 DCC ADAMTS12 PLA2R1 HMCN1 ROBO2 SEMA3E | 4.38e-09 | 193 | 172 | 10 | 9f69edc97b868d23998abc98928a2e89a885ef8a |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.38e-09 | 193 | 172 | 10 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | CASS4 COL5A2 FN1 LAMA4 SVEP1 ADAMTS12 TMEM132C HMCN1 ROBO2 MUSK | 4.38e-09 | 193 | 172 | 10 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.38e-09 | 193 | 172 | 10 | 30481fb01c7acf85beae10213f038da86bed6777 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | CASS4 COL5A2 FN1 LAMA4 DCC ADAMTS12 PLA2R1 HMCN1 ROBO2 SEMA3E | 4.60e-09 | 194 | 172 | 10 | 71d3c7448b1734de54187f902f65649f9283bd4c |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | ROBO4 HSPG2 PTPRT DENND4C PLEKHG1 EFNB2 ATRNL1 PPP1R16B ROBO2 KDR | 5.07e-09 | 196 | 172 | 10 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL5A2 FN1 LAMA4 SVEP1 ADAMTS12 TMEM132C IGSF10 HMCN1 ROBO2 MUSK | 5.33e-09 | 197 | 172 | 10 | 94a9603cbd3516fbcce871909693b88f20d41713 |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | CASS4 COL5A2 FN1 LAMA4 SVEP1 ADAMTS12 IGSF10 HMCN1 ROBO2 MUSK | 5.59e-09 | 198 | 172 | 10 | f1374f7a50244d59c766ac41f44c08c9117407d2 |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | CASS4 COL5A2 FN1 LAMA4 F10 SVEP1 ADAMTS12 IGSF10 HMCN1 ROBO2 | 5.87e-09 | 199 | 172 | 10 | 66a79732caf2f04c09b4d9832377aa01ca477677 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-08 | 160 | 172 | 9 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-08 | 160 | 172 | 9 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.69e-08 | 174 | 172 | 9 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.43e-08 | 179 | 172 | 9 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | Ciliated_cells-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.43e-08 | 179 | 172 | 9 | 0e6c22de2e3fb0ff23b3301863cf4011c5c59dff | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.78e-08 | 186 | 172 | 9 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.00e-08 | 187 | 172 | 9 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 5.00e-08 | 187 | 172 | 9 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.48e-08 | 189 | 172 | 9 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.00e-08 | 191 | 172 | 9 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.27e-08 | 192 | 172 | 9 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 6.27e-08 | 192 | 172 | 9 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.56e-08 | 193 | 172 | 9 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 6.56e-08 | 193 | 172 | 9 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.86e-08 | 194 | 172 | 9 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.86e-08 | 194 | 172 | 9 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 6.86e-08 | 194 | 172 | 9 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | COL5A2 IL13RA2 FN1 LAMA4 ADAMTS12 TMEM132C IGSF10 HMCN1 ROBO2 | 6.86e-08 | 194 | 172 | 9 | 29a72e565c19407bbd198cfbc2a78106fe830d05 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.16e-08 | 195 | 172 | 9 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.16e-08 | 195 | 172 | 9 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 7.16e-08 | 195 | 172 | 9 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.16e-08 | 195 | 172 | 9 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Fibroblasts|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.16e-08 | 195 | 172 | 9 | 5870b2956d50d6550a3174a220a6cc70c5538d70 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.48e-08 | 196 | 172 | 9 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | Bronchial_Biopsy-Mesenchymal|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.48e-08 | 196 | 172 | 9 | d37d821229dce716a05c2a5865415e10f79032de | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.48e-08 | 196 | 172 | 9 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.48e-08 | 196 | 172 | 9 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.48e-08 | 196 | 172 | 9 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.48e-08 | 196 | 172 | 9 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 7.48e-08 | 196 | 172 | 9 | b71b197cb92117dd9efaa13de000841901cc4ca8 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.48e-08 | 196 | 172 | 9 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 7.82e-08 | 197 | 172 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | PND14-Mesenchymal|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.82e-08 | 197 | 172 | 9 | 9a14bc2e7d6081e2ab0e2e5555fc8804f13d3dbe | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 8.52e-08 | 199 | 172 | 9 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.52e-08 | 199 | 172 | 9 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Mesothelial-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 8.52e-08 | 199 | 172 | 9 | 60a653100aff31f7f96796ff2ec634798bfb4b0d | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.52e-08 | 199 | 172 | 9 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.52e-08 | 199 | 172 | 9 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 8.89e-08 | 200 | 172 | 9 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.89e-08 | 200 | 172 | 9 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.89e-08 | 200 | 172 | 9 | a637281d91e95734ee4f8510b3780e0272b16fda | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 8.89e-08 | 200 | 172 | 9 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 2.01e-07 | 159 | 172 | 8 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 2.43e-07 | 163 | 172 | 8 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.55e-07 | 164 | 172 | 8 | 82e57d618c6e59bca4a03d31caf35b6043dfcf52 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.55e-07 | 164 | 172 | 8 | 2957065d7f1332c5280d47be7cc342286f84be3e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.75e-07 | 178 | 172 | 8 | e32f5ed7a492edfa7073416008b1fcfae6b854ad | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.75e-07 | 178 | 172 | 8 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.37e-07 | 185 | 172 | 8 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.37e-07 | 185 | 172 | 8 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 6.91e-07 | 187 | 172 | 8 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.91e-07 | 187 | 172 | 8 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 7.48e-07 | 189 | 172 | 8 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-07 | 190 | 172 | 8 | 251e3a33041023bfc4b547c7eb68cfb8f421636f | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 7.79e-07 | 190 | 172 | 8 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.10e-07 | 191 | 172 | 8 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.10e-07 | 191 | 172 | 8 | d04e6292fef189b8d8ed0f4b0c310b2b250fd30e | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.10e-07 | 191 | 172 | 8 | de3e9b704621b26836c2ddc39fa3e840dfb4541b | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.10e-07 | 191 | 172 | 8 | 997abf0cc5873bed0372c4a333ed307fa72774d2 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 8.43e-07 | 192 | 172 | 8 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-07 | 192 | 172 | 8 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-07 | 192 | 172 | 8 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.43e-07 | 192 | 172 | 8 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.43e-07 | 192 | 172 | 8 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.43e-07 | 192 | 172 | 8 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-07 | 192 | 172 | 8 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-07 | 192 | 172 | 8 | d2c03490c5e835d0f0a732803093c64b8d4b4029 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.43e-07 | 192 | 172 | 8 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.43e-07 | 192 | 172 | 8 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 8.76e-07 | 193 | 172 | 8 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.11e-07 | 194 | 172 | 8 | 5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.11e-07 | 194 | 172 | 8 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.11e-07 | 194 | 172 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 9.11e-07 | 194 | 172 | 8 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.11e-07 | 194 | 172 | 8 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.11e-07 | 194 | 172 | 8 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.47e-07 | 195 | 172 | 8 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.47e-07 | 195 | 172 | 8 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.47e-07 | 195 | 172 | 8 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 9.47e-07 | 195 | 172 | 8 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.47e-07 | 195 | 172 | 8 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.84e-07 | 196 | 172 | 8 | 97e26622d9582b092c18ff5b7e957818f99d9631 | |
| Drug | G 3012 | HSPG2 FN1 L1CAM SRMS DCC EFNB2 ROBO2 TBXT ROBO3 MYO15A SEMA3E | 4.90e-09 | 132 | 171 | 11 | CID000120739 |
| Drug | Methotrimeprazine maleat salt [7104-38-3]; Up 200; 9uM; PC3; HT_HG-U133A | 1.66e-06 | 188 | 171 | 10 | 3701_UP | |
| Drug | C-toxiferine-I | 2.08e-06 | 13 | 171 | 4 | CID005089093 | |
| Drug | tropicamide | 3.85e-06 | 32 | 171 | 5 | CID000005593 | |
| Drug | 6-bromocyclohex-4-ene-1,2,3-triol | 4.51e-06 | 33 | 171 | 5 | CID000122062 | |
| Drug | dinotefuran | 1.66e-05 | 21 | 171 | 4 | CID000197701 | |
| Drug | Molindone hydrochloride [15622-65-8]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.74e-05 | 195 | 171 | 9 | 4199_DN | |
| Drug | Tinidazole [19387-91-8]; Up 200; 16.2uM; HL60; HT_HG-U133A | 1.89e-05 | 197 | 171 | 9 | 2568_UP | |
| Drug | Isradipine [75695-93-1]; Up 200; 10.8uM; HL60; HT_HG-U133A | 2.04e-05 | 199 | 171 | 9 | 3129_UP | |
| Drug | Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; HL60; HG-U133A | 2.04e-05 | 199 | 171 | 9 | 1375_UP | |
| Drug | ipratropium bromide | 2.41e-05 | 46 | 171 | 5 | CID000003746 | |
| Drug | AC1L3BL8 | 2.43e-05 | 23 | 171 | 4 | CID000086457 | |
| Drug | Skpymrfamide | 2.43e-05 | 23 | 171 | 4 | CID000132661 | |
| Drug | procyclidine | 2.90e-05 | 24 | 171 | 4 | CID000004919 | |
| Drug | AC1NRAX5 | 3.38e-05 | 9 | 171 | 3 | CID005288137 | |
| Drug | pempidine | 3.44e-05 | 25 | 171 | 4 | CID000006603 | |
| Drug | beta-eudesmol | 4.04e-05 | 26 | 171 | 4 | CID000091457 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 5.73e-06 | 45 | 168 | 5 | DOID:3748 (is_implicated_in) | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 6.24e-06 | 7 | 168 | 3 | DOID:0050834 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 2.01e-05 | 261 | 168 | 9 | C0004352 | |
| Disease | hemorrhoid | 2.23e-05 | 147 | 168 | 7 | EFO_0009552 | |
| Disease | GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS, 1 | 3.22e-05 | 2 | 168 | 2 | C4551964 | |
| Disease | Gaze Palsy, Familial Horizontal, with Progressive Scoliosis | 3.22e-05 | 2 | 168 | 2 | C1846496 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 9.61e-05 | 16 | 168 | 3 | DOID:3635 (implicated_via_orthology) | |
| Disease | secretory phospholipase A2 receptor measurement | 9.63e-05 | 3 | 168 | 2 | EFO_0802043 | |
| Disease | sensory system disease (implicated_via_orthology) | 9.63e-05 | 3 | 168 | 2 | DOID:0050155 (implicated_via_orthology) | |
| Disease | smoking cessation | 1.09e-04 | 325 | 168 | 9 | EFO_0004319 | |
| Disease | Autosomal dominant nocturnal frontal lobe epilepsy | 1.92e-04 | 4 | 168 | 2 | cv:C3696898 | |
| Disease | Colorectal Carcinoma | CHL1 FN1 CD248 CALR OBSCN DCC PTPRT CAPN10 NF1 RHPN2 KDR TP53 HR | 2.04e-04 | 702 | 168 | 13 | C0009402 |
| Disease | ankle injury | 3.62e-04 | 59 | 168 | 4 | EFO_1002021 | |
| Disease | pancreatic cancer (is_implicated_in) | 4.63e-04 | 112 | 168 | 5 | DOID:1793 (is_implicated_in) | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 4.65e-04 | 63 | 168 | 4 | DOID:0050866 (is_marker_for) | |
| Disease | dietary heme iron intake measurement, type 2 diabetes mellitus | 4.76e-04 | 6 | 168 | 2 | EFO_0008355, MONDO_0005148 | |
| Disease | brain volume measurement, putamen volume | 4.76e-04 | 6 | 168 | 2 | EFO_0006930, EFO_0006932 | |
| Disease | Carcinoma, Granular Cell | 5.43e-04 | 116 | 168 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 5.43e-04 | 116 | 168 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 5.43e-04 | 116 | 168 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 5.43e-04 | 116 | 168 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 5.43e-04 | 116 | 168 | 5 | C0205641 | |
| Disease | Adenocarcinoma | 5.43e-04 | 116 | 168 | 5 | C0001418 | |
| Disease | Schizophrenia | CHL1 DDR1 PSAT1 CP DCC GRM8 CHRNA4 ADAMTS12 EFNB2 NCAN KDR HAGH PRL TP53 | 5.56e-04 | 883 | 168 | 14 | C0036341 |
| Disease | triacylglycerol 56:7 measurement | 5.94e-04 | 29 | 168 | 3 | EFO_0010434 | |
| Disease | myoclonic-atonic epilepsy (implicated_via_orthology) | 6.64e-04 | 7 | 168 | 2 | DOID:0060475 (implicated_via_orthology) | |
| Disease | Autosomal Dominant Nocturnal Frontal Lobe Epilepsy | 6.64e-04 | 7 | 168 | 2 | C3696898 | |
| Disease | MASA syndrome (implicated_via_orthology) | 6.64e-04 | 7 | 168 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | Malignant Glioma | 6.94e-04 | 70 | 168 | 4 | C0555198 | |
| Disease | mixed gliomas | 6.94e-04 | 70 | 168 | 4 | C0259783 | |
| Disease | Esophageal Neoplasms | 1.04e-03 | 78 | 168 | 4 | C0014859 | |
| Disease | schizophrenia (is_implicated_in) | 1.04e-03 | 78 | 168 | 4 | DOID:5419 (is_implicated_in) | |
| Disease | Malignant neoplasm of esophagus | 1.04e-03 | 78 | 168 | 4 | C0546837 | |
| Disease | Adenoma, Microcystic | 1.13e-03 | 36 | 168 | 3 | C0205648 | |
| Disease | Adenoma, Monomorphic | 1.13e-03 | 36 | 168 | 3 | C0205649 | |
| Disease | Adenoma, Basal Cell | 1.13e-03 | 36 | 168 | 3 | C0205646 | |
| Disease | Follicular adenoma | 1.13e-03 | 36 | 168 | 3 | C0205647 | |
| Disease | Papillary adenoma | 1.13e-03 | 36 | 168 | 3 | C0205650 | |
| Disease | Adenoma, Trabecular | 1.13e-03 | 36 | 168 | 3 | C0205651 | |
| Disease | Adenoma | 1.13e-03 | 36 | 168 | 3 | C0001430 | |
| Disease | Liver Diseases, Parasitic | 1.13e-03 | 9 | 168 | 2 | C0023897 | |
| Disease | pterygium (is_marker_for) | 1.13e-03 | 9 | 168 | 2 | DOID:0002116 (is_marker_for) | |
| Disease | colon carcinoma (is_implicated_in) | 1.13e-03 | 9 | 168 | 2 | DOID:1520 (is_implicated_in) | |
| Disease | Giant Cell Glioblastoma | 1.37e-03 | 84 | 168 | 4 | C0334588 | |
| Disease | linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] measurement | 1.41e-03 | 10 | 168 | 2 | EFO_0800499 | |
| Disease | Glioma | 1.56e-03 | 87 | 168 | 4 | C0017638 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.62e-03 | 148 | 168 | 5 | C0279702 | |
| Disease | Cognitive impairment | 1.71e-03 | 11 | 168 | 2 | HP_0100543 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 1.89e-03 | 43 | 168 | 3 | DOID:9261 (is_marker_for) | |
| Disease | cognitive decline measurement | FAM163A IGSF11 ACTN1 GRM8 TMEM132C PLEKHG1 ANAPC1 SCN2A CHD6 | 1.95e-03 | 486 | 168 | 9 | EFO_0007710 |
| Disease | Non-Small Cell Lung Carcinoma | 2.04e-03 | 156 | 168 | 5 | C0007131 | |
| Disease | TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) | 2.05e-03 | 12 | 168 | 2 | C1861063 | |
| Disease | linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] measurement | 2.05e-03 | 12 | 168 | 2 | EFO_0800500 | |
| Disease | thyroid gland carcinoma (is_marker_for) | 2.05e-03 | 12 | 168 | 2 | DOID:3963 (is_marker_for) | |
| Disease | Thrombocythemia, Essential | 2.05e-03 | 12 | 168 | 2 | C0040028 | |
| Disease | Myeloproliferative disease | 2.05e-03 | 12 | 168 | 2 | C0027022 | |
| Disease | diverticular disease | 2.39e-03 | 236 | 168 | 6 | EFO_0009959 | |
| Disease | acute myeloid leukemia (is_marker_for) | 2.76e-03 | 49 | 168 | 3 | DOID:9119 (is_marker_for) | |
| Disease | Sarcoma, Spindle Cell | 2.80e-03 | 14 | 168 | 2 | C0205945 | |
| Disease | Sarcoma, Epithelioid | 2.80e-03 | 14 | 168 | 2 | C0205944 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 2.88e-03 | 169 | 168 | 5 | DOID:3908 (is_marker_for) | |
| Disease | melanoma | 3.06e-03 | 248 | 168 | 6 | C0025202 | |
| Disease | delta-6 desaturase measurement | 3.22e-03 | 15 | 168 | 2 | EFO_0007765 | |
| Disease | chenodeoxycholate measurement | 3.22e-03 | 15 | 168 | 2 | EFO_0010471 | |
| Disease | lysophosphatidylethanolamine 18:0 measurement | 3.22e-03 | 15 | 168 | 2 | EFO_0010367 | |
| Disease | Malignant neoplasm of breast | FN1 KTN1 OBSCN TRMT11 ZNF318 SLAMF1 NF1 NISCH NUP133 UTP20 KDR DLEC1 TOR1AIP1 TP53 | 3.45e-03 | 1074 | 168 | 14 | C0006142 |
| Disease | level of triacylglycerol (56:6) in blood serum | 3.67e-03 | 16 | 168 | 2 | OBA_2020007 | |
| Disease | Spondyloepiphyseal Dysplasia | 3.67e-03 | 16 | 168 | 2 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 3.67e-03 | 16 | 168 | 2 | C3541456 | |
| Disease | Blood Coagulation Disorders | 3.67e-03 | 16 | 168 | 2 | C0005779 | |
| Disease | osteosarcoma (is_implicated_in) | 3.67e-03 | 16 | 168 | 2 | DOID:3347 (is_implicated_in) | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 3.67e-03 | 16 | 168 | 2 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 3.67e-03 | 16 | 168 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 3.67e-03 | 16 | 168 | 2 | C0025237 | |
| Disease | Glioblastoma Multiforme | 3.79e-03 | 111 | 168 | 4 | C1621958 | |
| Disease | factor VII measurement | 3.83e-03 | 55 | 168 | 3 | EFO_0004619 | |
| Disease | Van Buchem disease | 4.14e-03 | 17 | 168 | 2 | C0432272 | |
| Disease | Intellectual Disability | 4.23e-03 | 447 | 168 | 8 | C3714756 | |
| Disease | Hypertrophic Cardiomyopathy | 4.23e-03 | 57 | 168 | 3 | C0007194 | |
| Disease | sleep apnea measurement | 4.43e-03 | 116 | 168 | 4 | EFO_0007817 | |
| Disease | response to efavirenz, virologic response measurement | 4.45e-03 | 58 | 168 | 3 | EFO_0006904, EFO_0006906 | |
| Disease | Alcoholic Intoxication, Chronic | 4.46e-03 | 268 | 168 | 6 | C0001973 | |
| Disease | triacylglycerol 56:3 measurement | 4.64e-03 | 18 | 168 | 2 | EFO_0010430 | |
| Disease | Hemangiosarcoma | 4.64e-03 | 18 | 168 | 2 | C0018923 | |
| Disease | venous thromboembolism | 5.01e-03 | 460 | 168 | 8 | EFO_0004286 | |
| Disease | colorectal cancer (is_implicated_in) | 5.14e-03 | 121 | 168 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | Osteochondrodysplasias | 5.17e-03 | 19 | 168 | 2 | C0029422 | |
| Disease | Dyschondroplasias | 5.17e-03 | 19 | 168 | 2 | C0013366 | |
| Disease | Pheochromocytoma | 5.17e-03 | 19 | 168 | 2 | C0031511 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WLPVSKPESYNLENG | 81 | Q9HBT8 | |
| ASPDLSTGYWKLSPK | 981 | Q13075 | |
| YKPESSPGSRQIQLW | 31 | A0A1W2PQ73 | |
| YKPESSPGSRQIQLW | 16 | P50548 | |
| DGRVQWTPPAIYKSS | 146 | P43681 | |
| KSNGTVVWTPPASYK | 136 | Q05901 | |
| SWKPGASEGSAPIQY | 161 | Q63HQ2 | |
| PYTTITPQEINGKWD | 591 | P12814 | |
| SGTFNPVSLWANPKY | 196 | P54687 | |
| EWIYDTPVSPGKASV | 241 | Q9NQ75 | |
| GSEPWPYVVVKSTSE | 256 | Q8N5R6 | |
| WVPSNYITPVNSLEK | 156 | P42684 | |
| WKTQGEQSRPIPSAY | 111 | Q6QNK2 | |
| YRWVIHAGSKSPTEP | 726 | Q9HCU0 | |
| TPAWAKPTNTQAYSG | 531 | Q08345 | |
| KYTQPSLPSQAVWSQ | 426 | P54259 | |
| ISGESIYWSQKPTPS | 1166 | A8K2U0 | |
| LATAPGKPFWKAYTV | 36 | Q8WV93 | |
| FSTGTVHWVPPAIYK | 166 | Q15822 | |
| SWSPASIPGKHYQAV | 406 | Q9HC96 | |
| TLSGSYVAPKAVWLP | 711 | Q10567 | |
| NIYQDWLESSGIPKP | 646 | Q8N6M6 | |
| GSWKYPDLQASIPSV | 3071 | Q96M86 | |
| PQIKDISTQTKWTYP | 236 | Q8IWG1 | |
| GPYTDFTPWTTEEQK | 546 | Q99543 | |
| WQPSSKQEPVITDSY | 1241 | Q9Y485 | |
| ITWPVTPFYNTLTKG | 1136 | P58397 | |
| GTEKQPPAQPSYTWA | 861 | Q8TE57 | |
| TTYWISPQGIPETKV | 126 | Q14627 | |
| WSPEKVFVQTPTINY | 276 | Q8NCC3 | |
| YPTPDISWSKLDGSL | 3601 | P98160 | |
| DPYTDSWTPVSPALK | 396 | Q0D2K2 | |
| SWTPVSPALKYVSNF | 401 | Q0D2K2 | |
| EPSWVPASYLEKVVT | 301 | Q9P2A4 | |
| PPSIYQWVSSCLKGE | 841 | Q9H1A4 | |
| TYEWTVPKEVGPTNA | 516 | P00450 | |
| VTPTLPGETLTYVWK | 846 | P00450 | |
| LEKEPEYVPWTATSG | 756 | Q8WUM0 | |
| SWQPPLEANGKITAY | 966 | P43146 | |
| NPDSSTWKIYIRKAP | 386 | P51787 | |
| ITSPGWPSEYPAKIN | 61 | Q9Y561 | |
| PRWTKKPQSAVYSTG | 331 | O00533 | |
| EPQPWSSYGKRKTLT | 616 | Q7L2J0 | |
| LPPTQLEWTATYEKA | 2206 | Q9UKN7 | |
| PSTNVLDKTWPAAPY | 796 | Q9UBC5 | |
| NGTSPVYSREDLKPW | 1066 | Q9P2D0 | |
| AWAKEKYSIGEPTVP | 246 | Q16775 | |
| WYKDGQPVTPSSRLQ | 2681 | Q8NDA2 | |
| YSGEPWPSVSNLAKD | 316 | P11801 | |
| WVYSGGQPKVPSAFS | 186 | O43593 | |
| EPIYWNSSNSKFLPG | 31 | P52799 | |
| SISWYESSPKPQIQA | 1191 | Q9P2D6 | |
| PPDSSWRGSLKVSYN | 6 | Q9HBA9 | |
| GSTFDYIPWKGQTSP | 1471 | O60449 | |
| PKVSVPSNLSYGEWL | 1081 | Q86UP2 | |
| KWYSLGKVPGNQTST | 661 | P32004 | |
| NVVKDSWYSKLGPPT | 356 | Q8IXQ5 | |
| WPLSSSVPSQKTYQG | 91 | P04637 | |
| TWYRIGSESTKPPIT | 1246 | Q7Z3U7 | |
| IGSDSWGSKIAPVYQ | 306 | O00222 | |
| FIQPYWVGDSVSTPK | 41 | Q7Z7J7 | |
| AYPLTVGSIPKSQSW | 176 | Q86Y01 | |
| ISLGKESYPDLDPSW | 761 | Q02413 | |
| ECKAAGNPVPVITWY | 1941 | Q96RW7 | |
| IPSASLSWYKDGQPL | 2701 | Q96RW7 | |
| ILWDPPTIVTGKFSY | 366 | Q9UMZ3 | |
| WKPPNETNGVITLYE | 506 | O14522 | |
| GETEEQKCSTPVYPW | 116 | P17509 | |
| EGDPQPSVTWYKDSV | 6381 | Q5VST9 | |
| GVADATPPWSSYKEQ | 461 | Q96T49 | |
| TPPWSSYKEQSPQTL | 466 | Q96T49 | |
| TWPGVTQLPDYKGSF | 226 | Q00526 | |
| QNDTVTPDVWYTSKP | 376 | Q9BTY2 | |
| NTAYPSLKPLGSWVK | 3951 | Q9C0G6 | |
| AKGTPQPSVYWVLSD | 1866 | Q6WRI0 | |
| SSEEGIPRPTYLWEK | 166 | Q5DX21 | |
| PATNSWAYVAPLKRE | 421 | Q53GT1 | |
| GTSIAWNSPKPEYFL | 111 | A0A1B0GVN3 | |
| TEDTWPGVSKLPNYN | 321 | Q96Q40 | |
| GKPSPWLSVDTALYI | 316 | A8K855 | |
| GKWPSSQQYEPSGTL | 2111 | Q8TD26 | |
| KLGAYPWSQSSPALN | 416 | Q9BQN1 | |
| VKWLPSSSPVTGYRV | 1651 | P02751 | |
| EYRKPIDWGAASPAV | 156 | P22914 | |
| YGSPSITDWLPSNKS | 306 | Q6P4F1 | |
| WSAYKGKSPQTPELV | 696 | Q9NX05 | |
| KGTWIHPEIDNPEYS | 286 | P27797 | |
| YNKVVLESPWPSSTR | 861 | Q5VZ89 | |
| STESYWILPNVKPFS | 286 | Q5VV63 | |
| GSPLKAYTPVVVTQW | 576 | Q9UQ88 | |
| ASKSPDNKPVWYGLD | 1351 | P05997 | |
| WASEAYSPQGLKPVV | 16 | O14548 | |
| QAKALPSPAATIWDY | 351 | Q6ZN28 | |
| PSGFAQWRPVAYSQK | 276 | Q8WWB7 | |
| KPGETFTYKWTVPES | 511 | Q6MZM0 | |
| STYSVAQVPRWKPQA | 576 | O00754 | |
| GATIECWPAQTKYPV | 241 | O75064 | |
| SLKLAAPQSYPVTWP | 136 | Q96GL9 | |
| PEVSGIWPKYTEVTD | 506 | Q6ZMW3 | |
| PKNGPIYDVVWNSSS | 271 | Q9BY44 | |
| SGEAPDSITWKPYDA | 191 | P00742 | |
| APGTIVEVWKDSAYP | 416 | P07686 | |
| DVTFKSTNPYGWPQI | 71 | Q9UPM9 | |
| PSQPTWKSSLYSSLA | 36 | Q9Y238 | |
| VDDSNLVYPPKDGVW | 4316 | Q9P225 | |
| PKAAGYANPVWTALF | 36 | Q16584 | |
| YKQWSSSAPNLVKGP | 646 | P80192 | |
| LSADGQSEPPYTTWK | 351 | Q9UK39 | |
| QSEPPYTTWKIRTSG | 356 | Q9UK39 | |
| SSDTWGLVPYSKPIT | 321 | Q96PD7 | |
| YNWVTTPTTFKPDSP | 951 | Q9BZA8 | |
| EIPLDSKPVSSWPAY | 916 | Q16363 | |
| SKPVSSWPAYFSIVK | 921 | Q16363 | |
| AVEVQTYQPPWKALS | 291 | Q96A47 | |
| WPHQLTVEKTPAYFT | 111 | O14792 | |
| HPETKENEIYPVWSG | 166 | P01236 | |
| TTVELYWSLPEKPNG | 3696 | O75445 | |
| WSPPTVQNGKITKYL | 4376 | O75445 | |
| LPPNKDTTYLSQSWA | 506 | O75691 | |
| QETYGKSPFWILSIP | 41 | Q7Z4G4 | |
| TEEKLKSYQPWGNVP | 421 | Q9BYT3 | |
| ISKPAPYWEGTAVID | 81 | Q13162 | |
| SGTQPITWQVEYPRK | 396 | Q8N3T6 | |
| GPAIPEVSSVWFKQY | 166 | P0C866 | |
| GLPQVWSPVEKTYHS | 926 | A0AVI2 | |
| WKNGAYTLPKSIQPT | 1226 | A0AVI2 | |
| SSWKYPTNAPGAFRV | 761 | Q8N3V7 | |
| PNPWIRSYTLAGKEE | 356 | Q96MK3 | |
| YWVINPADSSGITPK | 651 | Q8NFP9 | |
| DEVQDPWPSVYSKGL | 776 | O14594 | |
| YTKIPDPSTWNLNPD | 131 | Q9Y617 | |
| LPWSTGYAEVINAGK | 101 | Q5JR12 | |
| DPSETKPWAVYAGLL | 231 | Q13291 | |
| ATKYPAEEPASAWTP | 1096 | Q5T5P2 | |
| WSITDGYVPILGNKT | 86 | Q969X2 | |
| TQSVIPTGKEYLEWP | 556 | Q6ZUB1 | |
| TAPYKWTGSAPILQQ | 241 | P49221 | |
| VNGKPYTGPEVDSWS | 221 | Q9H093 | |
| VSPDYNWFRGTVPLK | 6 | Q9NZD8 | |
| SKIPVKWTAPEAANY | 386 | Q9H3Y6 | |
| DLICTEKGVWSQPYP | 3101 | Q4LDE5 | |
| SRPWEKTDKGATYTP | 241 | Q53GL0 | |
| APVKENIPYSWASLA | 331 | Q8IUC4 | |
| GKPVVYSNWSPFDII | 1036 | Q13018 | |
| LSWKVSGPAAPAQSY | 266 | Q8WZ75 | |
| PKAESEQLASWTPYP | 56 | Q6ZRI6 | |
| EIYTIKWSPTGPATS | 456 | O60907 | |
| IKVWDYATQASPGPQ | 951 | Q96KV7 | |
| KTHEKYGWVTPPVSD | 146 | A1L167 | |
| EHQGTLPWQKPYTSV | 121 | Q6P9A3 | |
| PSVLSSGYQKTPQEW | 276 | Q5JTV8 | |
| VQWSTPKLPFTQSIY | 341 | Q8WVR3 | |
| SYWVDEKSPVGPDQT | 61 | Q0VAA5 | |
| SESWSPIQSRIPAYK | 6 | Q8NBB2 | |
| TKRVLPPNWKYESST | 131 | P62277 | |
| PPNWKYESSTASALV | 136 | P62277 | |
| WKPNPQTGAAVTSYV | 576 | Q96MS0 | |
| APSEAVKSAAIPYWL | 896 | Q9Y2I1 | |
| PPDWTKNVEYTFTGI | 151 | Q99250 | |
| VLKIPASWTNPSGKY | 96 | P29144 | |
| GDPSYRTLKETQPWS | 2481 | P21359 | |
| TQPWSSPKGSEGYLA | 2491 | P21359 | |
| NCKAEGRPTPTIEWY | 51 | Q9HCK4 | |
| AKTNLTWYGITSPTP | 1471 | P08922 | |
| VSISGVYPSENKPWH | 196 | Q68DE3 | |
| QYPSLWSVSNGAVTP | 346 | O15178 | |
| SKEIYTIKWSPTGPA | 401 | Q9BQ87 | |
| VWYPATALADNKPVA | 186 | Q9NNW5 | |
| LYEETNKETWGPATP | 61 | Q9UFV1 | |
| SWKQPPLSTVPADGY | 461 | Q9C026 | |
| AQLYSTLKEGNPPWE | 421 | Q9Y5L0 | |
| SRSPPYTDDVKWLLG | 1691 | A7E2V4 | |
| FWTPDIPLSSYVKGI | 171 | Q5R3I4 | |
| CPAQSSISQGAKPWY | 696 | O15041 | |
| STFENLTWYKLGPQP | 576 | P35968 | |
| TNWKGPDLTSYGELV | 311 | Q9ULL1 | |
| GDPILTYFPKWSVIS | 211 | Q6NUS6 | |
| VPYTPQITAWDLEGK | 86 | Q9BT76 | |
| TQTLDPYNRPWASKT | 1091 | Q5VUA4 | |
| PYNRPWASKTQSEAK | 1096 | Q5VUA4 | |
| FYTKWNPEALPSNTG | 676 | P35573 | |
| VESYPQPEISWTRNK | 51 | O15146 | |
| PTPVVQWYKDGSLIC | 181 | P54296 |